Abstract
The mechanisms leading to sarcopenia, the main cause for frailty in older adults, are still unclear. Autophagy and the ubiquitin‐proteasome system (UPS) may play a role in mediating muscle protein breakdown related to sarcopenia. In addition to loss of muscle mass, compromised muscle performance observed in sarcopenic patients has been linked to muscle mitochondria dysfunction. Increased fat deposition and fat cell infiltration in muscle frequently seen in skeletal muscle of older adults may play an additional role for the pathogenesis of sarcopenia. Therefore, the first objective of this study was to understand differences in expression of genes related to autophagy, UPS, mitochondrial biogenesis, and fat metabolism in skeletal muscle of older adults compared with young adults. Our second objective was to determine the correlation between whole body protein kinetics (WBPK) and gene expression with age. Real‐time quantitative PCR was used to determine the relative expression of targeted genes, and hierarchical regression analysis was used to determine if age had a moderating effect on the correlation between expression of targeted genes and WBPK. Increases in the expression of autophagy‐related genes and fat metabolism‐related genes were observed in muscle of older adults compared with young adults. In addition, age enhanced the negative correlations between mitochondrial biogenesis genes and net protein balance. These results suggest that dysregulated gene expression of mitochondrial biogenesis could play a role in muscle loss in older adults.
Keywords: autophagy, muscle, protein breakdown, protein synthesis, sarcopenia
The objective of this study was to understand differences in expression of genes related to autophagy, UPS, mitochondrial biogenesis, and fat metabolism in skeletal muscle of older adults compared with young adults and to determine the correlation between whole body protein kinetics (WBPK) and gene expression with age.These results suggest that dysregulated gene expression of autophagy, mitochondrial biogenesis, and fat metabolism could play a role in muscle loss in older adults.

Key Points Summary.
Age increases expression of autophagy and fat metabolism genes in skeletal muscle.
There was an age‐dependent negative correlation between net protein balance and mitochondrial biogenesis‐related gene expression.
These results provide a link between changes in whole body protein kinetics (physiology) and dysregulated pathways (molecular mechanisms) in skeletal muscle of older adults.
1. INTRODUCTION
There are approximately 49 million adults aged 65 and older in the United States, and it is estimated that this population will grow to 98 million by 2060 (Living AfC, 2018). As we age, there is a gradual loss of skeletal muscle mass and function (Janssen, Heymsfield, & Ross, 2002), called sarcopenia (Gillespie et al., 2012; Vellas, Wayne, Romero, Baumgartner, & Garry, 1997), which may be caused by a decrease in muscle protein synthesis, an increase in muscle protein breakdown, or a combination of those responses (Baum, Kim, & Wolfe, 2016). For example, myofibrillar protein fractional synthesis rate (FSR) and sarcoplasmic protein FSR are reported to be lower in older adults compared to young adults (Cuthbertson et al., 2005). There is also a negative correlation between age and whole body amino acid kinetics (reflecting protein kinetics) such as phenylalanine and leucine flux with age, which would be consistent with accelerated protein breakdown in aging (Short, Vittone, Bigelow, Proctor, & Nair, 2004). Impairment of muscle protein synthesis has been shown to be associated with dysregulation of muscle protein synthesis‐related signaling in older adults (Guillet et al., 2004). However, no difference in muscle fractional breakdown rate has been observed between young and old adults (Fry et al., 2013). This has been further supported by additional studies demonstrating no difference in muscle protein breakdown rates between healthy young and older adults (Katsanos, Kobayashi, Sheffield‐Moore, Aarsland, & Wolfe, 2005; Volpi, Sheffield‐Moore, Rasmussen, & Wolfe, 2001). These apparently contradictory findings demonstrate the importance of gaining further understanding into the regulation of muscle protein synthesis and breakdown in older adults.
Activation of the autophagic lysosomal system is related to loss of muscle protein in catabolic states (Neel, Lin, & Pessin, 2013). However, the relation of autophagy to muscle loss with aging has not been established (White et al., 2016; Zhou et al., 2017). Autophagy is usually activated to recycle energy from intracellular damaged organelles and misfolded proteins (Levine & Klionsky, 2004). All misfolded proteins and organelles are engulfed in the autophagosome, then, fused with the lysosome. Degradation of engulfed proteins and organelles produces energy for other pathways, such as protein synthesis, to help cells overcome the crisis state (Sandri, 2010). When autophagy occurs in mitochondria, it is called mitophagy (Zhang, 2013). Increased occurrence of mitophagy indicates an increase in dysfunctional mitochondria (Kim, Rodriguez‐Enriquez, & Lemasters, 2007). It has been suggested that the accumulation of dysfunctional mitochondria in muscle leads to decreased physical performance (Drummond et al., 2014), and upregulated mitophagy decreases availability of functional mitochondria (Carter, Kim, Erlich, Zarrin‐Khat, & Hood, 2018), indicating that higher level of mitophagy or increased autophagy flux might be the potential mechanism in the development of age‐related sarcopenia in the skeletal muscle of older adults.
In addition to the possible upregulation of autophagy in sarcopenia, the ubiquitin‐proteasome pathway (UPS) may also be upregulated (Clavel et al., 2006). Two major muscle‐specific E3 ubiquitin ligases, muscle ring finger 1 (MuRF1) and muscle atrophy F‐box (MAFbx, also known as Atrogin‐1), are upregulated at mRNA level in human and rats (Clavel et al., 2006; Drummond et al., 2014) and at protein level in rats under muscle atrophy conditions (Altun et al., 2010). In addition, two genes were identified to be necessary for mediating muscle atrophy, growth arrest DNA damage‐inducible 45a (GADD45A; Baehr et al., 2016; Bullard et al., 2016) and activating transcription factor 4 (ATF4; Ebert et al., 2020; Fox et al., 2014). To date, no study compared the expression of Atrogin1, MuRF1, GADD45A, and ATF4 in skeletal muscle of older adults with those of young adults.
Another frequently reported feature of aging skeletal muscle is the imbalance between fat mass and muscle mass within skeletal muscle (Guo & Jensen, 2013). It has been previously reported that intramyocellular fat is greater in older adults when compared with their young counterparts (Hamrick, McGee‐Lawrence, & Frechette, 2016). It has been suggested that accumulated fat mass, whether infiltrated intracellularly or surrounding the muscle cells, accelerates muscle loss with age (Buch et al., 2016). Reduced fat oxidation was shown in muscle of middle‐aged adults compared with young adults (Blaak, van Baak, & Saris, 1999). It is clear that fat oxidation is reduced in skeletal muscle of older adults. However, gene expression related to fat oxidation and fat synthesis are still unknown in the skeletal muscle from older adults.
Therefore, the first objective of this study was to determine differences in gene expression related to autophagy, UPS, mitochondria, and fat metabolism in the skeletal muscle between older and young adults. Our second objective was to determine whether age has a moderating (enhancing or buffering) effect on the correlation between gene expression and whole‐body protein kinetics: protein synthesis rate (PS), protein breakdown rate (PB), and net protein balance (NB).
2. MATERIALS AND METHODS
2.1. Skeletal muscle biopsies
This study is a secondary analysis of skeletal muscle (vastus lateralis) samples from two previously published studies (Kim, Schutzler, et al., 2016; Kim et al., 2015). In total, 30 healthy adults including eleven young (18–40 years) and nineteen older adults (52–75 years) were recruited from the Little Rock area using local newspaper advertisements and flyers posted around the University of Arkansas for Medical Sciences campus and the Little Rock area. The study was conducted according to the declaration of Helsinki and a written informed consent was obtained from all participants. The study was approved by the Institutional Review Board at the University of Arkansas for Medical Sciences. Exclusion criteria is described in the original published article (Kim et al., 2015). For the current study, we analyzed the baseline muscle samples collected after an overnight fast. Characteristics of all adults are shown in Table 1.
TABLE 1.
Participant characteristics
| Young | Old | |
|---|---|---|
| Age | 31.0 ± 5.3 | 65.5 ± 6.1 |
| Female/male | 7/4 | 9/10 |
| Body weight, kg | 82.7 ± 21.4 | 80.0 ± 14.8 |
| BMI, kg/m2 | 26.0 ± 5.5 | 28.0 ± 3.0 |
| LBM, kg | 55.0 ± 12.3 | 50.0 ± 12.0* |
| Fat mass, kg | 23.0 ± 9.3 | 27.8 ± 7.0* |
Values are expressed as mean ± SD.
Abbreviations: BMI, body mass index; LBM, lean body mass.
p < .05.
2.2. Stable isotope tracer infusion and calculations of whole‐body protein kinetics
The detailed stable isotope tracer infusion protocol and calculations of protein kinetics have been described in previously published papers (Kim, Schutzler, et al., 2016; Kim et al., 2015). Briefly, after an overnight fast, two 18‐gauge catheters were placed in each lower arm, one for the stable isotope infusion and one for blood sample collection. Primed continuous infusions of L‐ring‐2H5‐phenylalanine (prime, 3.07 μmol/kg; rate, 5.04 μmol kg−1 hr−1) were performed. A priming dose of L‐ring‐2H4‐tyrosine was injected (prime, 0.44 μmol/kg) to reach isotopic equilibrium of L‐ring‐2H4‐tyrosine enrichment derived from L‐ring‐2H5‐phenylalanine infusion. The muscle biopsy used in the present study was taken 2 hr after the initiation of the tracer infusion.
Whole body PS and PB rate were calculated based on the determinations of the rate of appearance (R a) into the plasma of phenylalanine and tyrosine and the fractional R a of endogenous tyrosine converted from phenylalanine (Kim, Suh, Lee, & Wolfe, 2016; Wolfe, 2005). Equations used for kinetic calculations were described (Kim, Suh, et al., 2016; Wolfe, 2005).
2.3. Quantitative real‐time PCR
RNA samples were isolated using TRIzol reagent (Invitrogen), following manufacturer instructions. Then, cDNA samples were synthesized based on the concentration of RNA samples in accordance with manufacturer instruction using Roche Lightcycler 480 system. SYBR green master mix (Quanta) was used as the reporter dye for mitochondrial biogenesis‐related genes: peroxisome proliferator‐activated nuclear receptor‐gamma (PPARγ), Peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha (PGC‐1α), transcription factor A mitochondrial (Tfam), uncoupling protein 2 (UCP2), and nuclear respiratory factor 1 (NRF1); fatty acid metabolism‐related genes: carnitine palmitoyltransferase I (Cpt1b), acetyl‐CoA carboxylase (ACC), fatty acid transporter protein 1 (FATP1), fatty acid transporter 4 (FATP4), peroxisome proliferator‐activated receptor‐alpha (PPARα), sterol regulatory element binding protein 1 (SREBP1); autophagy and ubiquitin‐proteasome‐related genes: nucleoporin 62 (p62), autophagy related 3 (ATG3), autophagy related 5 (ATG5), autophagy related 7 (ATG7), microtubule‐associated proteins 1A/1B light chain 3B (LC3B), nucleoporin 53 (p53), Unc‐51 like autophagy activating kinase 1 (ULK1), Beclin1, growth arrest and DNA damage inducible alpha (GADD45A), activating transcription factor 4 (ATF4), Atrogin1, and muscle RING‐finger protein 1 (MuRF1). All primer sequences are provided in the supplementary table (Table S1). All primers were ordered from Integrated DNA Technologies. All samples and controls were analyzed in duplicate. Fold change of target genes of old group versus young group were determined using 2−ΔΔCt method (Livak & Schmittgen, 2001).
2.4. Statistical analysis
For RT‐PCR results, multiple t test was used for comparing difference between young and old groups. Holm–Sidak method was used for correcting multiple comparisons (Aickin & Gensler, 1996). Statistical analyzes were performed and figures were plot in Graphpad Prism, version 6 (San Diego, CA, USA). Hierarchical linear regression analysis was performed to examine the moderating effect of age on the relations between gene expression and whole‐body protein kinetics (i.e., protein synthesis, protein breakdown, or net balance). We set BMI as a control variable in the first step (Step 1) due to its impact on protein turnover rate. Next, gene expression was entered as independent variables in the second step (Step 2). Then, we entered age as the moderator variable in the third step (Step 3). Finally, we added the two‐way interaction terms (gene × age) in the fourth step (Step 4). We confirmed that there was no multicollinearity among independent variables by examining variance inflation factors (VIF) and tolerance. Statistical analyzes were performed using IBM SPSS statistics, version 23 (Chicago, IL, USA). All significance level was set at 0.05 (α = 0.05). All p values that lower than 0.05 were considered significant.
3. RESULTS
3.1. Whole body protein kinetics
Whole body protein kinetics (WBPK) are shown in Figure 1. Older adults showed a decrease in both PS and PB compared with young adults (p < .01). The NB of older adults was significantly lower than young adults (p < .01).
FIGURE 1.

Whole body protein kinetics in skeletal muscle from young and old adults. PS, protein synthesis rate; PB, protein breakdown rate; NB, net balance; LBM, lean body mass. Values represent mean ± SD (young: n = 11, old: n = 19; *p < .05; Student t test with Holm–Sidak method)
3.2. Autophagy gene expression, and effect of age on correlation with whole body protein kinetics
Expression of autophagy genes in older compared with young muscle is shown in Figure 2. There was an upregulation in the gene expression of p62 (p < .001), ATG7 (p < .001), Beclin1 (p < .01), and p53 (p < .001) in the older adults, compared with young adults. In the hierarchical regression analysis, we found that age has significant moderating effects on the relationship between gene expression (p53 and ULK1) and NB (ΔR 2 = 2.7% for p53 and 3.8% for ULK1, p < .05 for both; Table 2).
FIGURE 2.

Expression of autophagy genes in skeletal muscle from young and old adults. P62, nucleoporin 62; ATG3, autophagy related 3; ATG5, autophagy related 5; ATG7, autophagy related 7; LC3B, microtubule‐associated proteins 1A/1B light chain 3B; p53, nucleoporin 53; ULK1, Unc‐51 like autophagy activating kinase 1; GADD45A, growth arrest and DNA damage inducible alpha; ATF4, activating transcription factor 4. Values represent mean ± SD (young: n = 11, old: n = 19; *p < .05; Student t test with Holm–Sidak method)
TABLE 2.
Hierarchical regression analysis of correlation between autophagy gene expression and whole‐body protein kinetics
| Autophagy | PS | PB | NB | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | B | SE | β | ΔR 2 | B | SE | β | ΔR 2 | B | SE | β | ΔR 2 |
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.008 | 0.028 | 0.013 | |||||||||
| ATF4 | 0.114 | 0.232 | 0.094 | 0.175 | 0.191 | 0.175 | −0.061 | 0.096 | −0.122 | |||
| Step3 | 480*** | 0.159* | 0.788*** | |||||||||
| AGE | 0.203 | 0.037 | 0.718*** | 0.096 | 0.041 | 0.413* | 0.106 | 0.009 | 0.919*** | |||
| Step4 | 0.006 | 0.010 | 0.000 | |||||||||
| ATF4 X AGE | 0.006 | 0.010 | 0.081 | 0.007 | 0.011 | 0.109 | −0.001 | 0.003 | −0.023 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | . | ||
| Step2 | 0.020 | 0.042 | 0.005 | |||||||||
| ATG3 | 0.121 | 0.154 | 0.146 | 0.145 | 0.127 | 0.212 | −0.024 | 0.065 | −0.071 | |||
| Step 3 | 0.477*** | 0.156* | 0.790*** | |||||||||
| AGE | 0.202 | 0.037 | 0.715*** | 0.095 | 0.040 | 0.410* | 0.107 | 0.009 | 0.921*** | |||
| Step4 | 0.016 | 0.040 | 0.008 | |||||||||
| ATG3 X AGE | 0.007 | 0.006 | 0.129 | 0.008 | 0.007 | 0.201 | −0.002 | 0.002 | −0.089 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | . | ||
| Step2 | 0.003 | 0.012 | 0.006 | |||||||||
| ATG5 | 0.057 | 0.181 | 0.060 | .0.090 | 0.151 | 0.114 | −0.032 | 0.075 | −0.82 | |||
| Step3 | 0.479*** | 0.158* | 0.790*** | |||||||||
| AGE | 0.202 | 0.038 | 0.717*** | .0.096 | 0.041 | 0.412* | 0.107 | 0.009 | 0.920*** | |||
| Step4 | 0.002 | 0.008 | 0.004 | |||||||||
| ATG5 X AGE | −0.003 | 0.008 | 0.050 | 0.005 | 0.009 | 0.093 | −0.002 | 0.002 | −0.064 | |||
| Step1 | ||||||||||||
| BMI | 0.291 | 0.213 | 0.25 | 0.202 | 0.178 | 0.210 | 0.089 | 0.089 | 0.187 | |||
| Step2 | 0.000 | 0.014 | 0.047 | |||||||||
| ATG7 | 0.009 | 0.185 | 0.010 | 0.098 | 0.153 | 0.125 | −0.088 | 0.075 | −0.228 | |||
| Step3 | 0.498*** | 0.180* | 0.750*** | |||||||||
| AGE | 0.208 | 0.038 | 0.739*** | 0.103 | 0.042 | 0.444* | 0.105 | 0.010 | 0.907*** | |||
| Step4 | 0.020 | 0.026 | 0.000 | |||||||||
| ATG7 X AGE | 0.009 | 0.009 | 0.150 | 0.009 | 0.010 | 0.170 | 0.001 | 0.002 | 0.023 | |||
| Step1 | ||||||||||||
| BMI | 0.287 | 0.210 | 0.255 | 0.186 | 0.0165 | 0.212 | 0.102 | 0.087 | 0.220 | |||
| Step2 | 0.004 | 0.004 | 0.001 | |||||||||
| Beclin1 | −0.061 | 0.192 | −0.067 | −0.048 | 0.151 | −0.067 | −0.013 | 0.079 | −0.036 | |||
| Step3 | 0.561*** | 0.243** | 0.797*** | |||||||||
| AGE | 0.217 | 0.035 | 0.779*** | 0.111 | 0.038 | 0.512** | 0.106 | 0.009 | 0.929*** | |||
| Step4 | 0.005 | 0.014 | 0.003 | |||||||||
| Beclin1 X AGE | 0.004 | 0.008 | 0.077 | 0.006 | 0.008 | 0.130 | −0.001 | 0.002 | −0.059 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.015 | 0.036 | 0.008 | |||||||||
| GADD45A | 0.129 | 0.194 | 0.123 | 0.169 | 0.160 | 0.194 | −0.039 | 0.081 | −0.091 | |||
| Step3 | 0.479*** | 0.158* | 0.789*** | |||||||||
| AGE | 0.202 | 0.037 | 0.717*** | .0.096 | 0.040 | 0.412* | 0.107 | 0.009 | 0.920*** | |||
| Step4 | 0.019 | 0.041 | 0.005 | |||||||||
| GADD45A X AGE | 0.010 | 0.009 | 0.141 | .0.012 | 0.010 | 0.205 | −0.002 | 0.002 | −0.068 | |||
| Step1 | ||||||||||||
| BMI | 0.307 | 0.212 | 0.264 | 0.203 | 0.176 | 0.212 | 0.104 | 0.086 | 0.223 | |||
| Step2 | 0.006 | 0.002 | 0.009 | |||||||||
| ULK1 | 0.021 | 0.051 | 0.074 | 0.010 | 0.043 | 0.045 | 0.010 | 0.021 | 0.093 | |||
| Step3 | 0.479*** | 0.168* | 0.780*** | |||||||||
| AGE | 0.208 | 0.037 | 0.732*** | 0.101 | 0.043 | 0.434* | 0.106 | 0.010 | 0.934*** | |||
| Step4 | 0.007 | 0.040 | 0.038* | |||||||||
| ULK1 X AGE | −0.001 | 0.002 | −0.090 | −0.003 | 0.002 | −0.210 | 0.001 | 0.000 | 0.204* | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.006 | 0.012 | 0.001 | |||||||||
| LC3B | 0.069 | 0.165 | 0.082 | 0.083 | 0.137 | 0.119 | −0.014 | 0.069 | −0.039 | |||
| Step3 | 0.485*** | 0.162* | 0.787*** | |||||||||
| AGE | 0.204 | 0.037 | 0.721*** | 0.097 | 0.041 | 0.418* | 0.106 | 0.010 | 0.919*** | |||
| Step4 | 0.007 | 0.017 | 0.004 | |||||||||
| LC3B X AGE | 0.004 | 0.007 | 0.088 | 0.006 | 0.008 | 0.139 | −0.001 | 0.002 | −0.065 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.003 | 0.015 | 0.011 | |||||||||
| P62 | 0.041 | 0.129 | 0.061 | 0.071 | 0.107 | 0.128 | −0.030 | 0.054 | −0.108 | |||
| Step3 | 0.489*** | 0.167* | 0.779*** | |||||||||
| AGE | 0.205 | 0.037 | 0.726*** | 0.099 | 0.041 | 0.424* | 0.106 | 0.010 | 0.916*** | |||
| Step4 | 0.022 | 0.045 | 0.005 | |||||||||
| P62 X AGE | 0.006 | 0.005 | 0.151 | 0.007 | 0.006 | 0.217 | −0.001 | 0.001 | −0.068 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | .0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.019 | 0.003 | 0.054 | |||||||||
| P53 | −0.086 | 0.113 | −0.139 | −0.027 | 0.095 | −0.052 | −0.060 | 0.046 | −0.234 | |||
| Step3 | 0.462*** | 0.157* | 0.741*** | |||||||||
| AGE | 0.201 | 0.038 | 0.714*** | 0.097 | 0.042 | 0.416* | 0.105 | 0.009 | 0.904*** | |||
| Step4 | 0.002 | 0.001 | 0.027* | |||||||||
| P53 X AGE | 0.002 | 0.006 | 0.049 | −0.001 | 0.007 | −0.035 | 0.003 | 0.001 | 0.191* | |||
Step 1 = control variable; Step 2 = independent variable; Step 3 = moderator variable; Step 4 = interaction terms; B = unstandardized regression coefficient; SE = standard errors for unstandardized regression coefficient; β = standardized regression coefficient; ΔR 2 = changes in R 2; PS = protein synthesis rate; PB = protein breakdown rate; NB = protein net balance; BMI = body mass index; ATF4 = activating transcription factor 4; ATG3 = autophagy related 3; ATG5 = autophagy related 5; ATG7 = autophagy related 7; Beclin1 = mammalian ortholog of yeast Atg6; GADD45A = growth arrest and DNA damage inducible alpha; ULK1 = unc‐51 like autophagy activating kinase 1; LC3B = microtubule associated protein 1 light chain 3 beta; p62 = ubiquitin‐binding protein p62; p53 = tumor protein p53.
p < .05;
p < .01;
p < .001.
3.3. Ubiquitin‐proteasome system gene expression, and effect of age on correlation with whole body protein kinetics
Expression of ubiquitin‐proteasome system (UPS) genes in older compared with young muscle is shown in Figure 3. MuRF1 and Atrogin‐1 showed no significant difference between older and young adults. In the hierarchical analysis, we found no moderating effects of age on the relationship between any of UPS gene expression and dependent variables (Table 3).
FIGURE 3.

Expression of UPS genes in skeletal muscle from young and old adults. Atrogin1, muscle atrophy F‐box; MuRF1, muscle RING‐finger protein 1. Values represent mean ± SD (young: n = 11, old: n = 19; Student t test with Holm–Sidak method)
TABLE 3.
Hierarchical regression analysis of correlation between UPS gene expression and whole‐body protein kinetics
| UPS | PS | PB | NB | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | B | SE | β | ΔR 2 | B | SE | β | ΔR 2 | B | SE | β | ΔR 2 |
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.010 | 0.001 | 0.096 | |||||||||
| Atrogin‐1 | −0.090 | 0.165 | −0.099 | 0.026 | 0.138 | 0.034 | −0.115 | 0.065 | −0.311 | |||
| Step3 | 0.471*** | 0.167* | 0.726*** | |||||||||
| AGE | 0.203 | 0.038 | 0.718*** | 0.099 | 0.042 | 0.427* | 0.103 | 0.009 | 0.891*** | |||
| Step4 | 0.016 | 0.020 | 0.001 | |||||||||
| Atrogin‐1 X AGE | −0.007 | 0.007 | 0.129 | 0.007 | 0.008 | 0.144 | 0.001 | 0.002 | 0.023 | |||
| Step1 | ||||||||||||
| BMI | 0.291 | 0.213 | 0.250 | 0.202 | 0.178 | 0.210 | 0.089 | 0.089 | 0.187 | |||
| Step2 | 0.001 | 0.008 | 0.067 | |||||||||
| MuRF1 | −0.037 | 0.221 | −0.032 | 0.089 | 0.184 | 0.093 | −0.126 | 0.089 | −0.267 | |||
| Step3 | 0.488*** | 0.175* | 0.739*** | |||||||||
| AGE | 0.206 | 0.039 | 0.731*** | 0.102 | 0.042 | 0.438* | 0.104 | 0.009 | 0.900*** | |||
| Step4 | 0.007 | 0.009 | 0.000 | |||||||||
| MuRF1 X AGE | 0.007 | 0.011 | 0.089 | 0.006 | 0.012 | 0.099 | 0.001 | 0.003 | 0.018 | |||
Step 1 = control variable; Step 2 = independent variable; Step 3 = moderator variable; Step 4 = interaction terms; B = unstandardized regression coefficient; SE = standard errors for unstandardized regression coefficient; β = standardized regression coefficient; ΔR 2 = changes in R 2; PS = protein synthesis rate; PB = protein breakdown rate; NB = protein net balance; BMI = body mass index; atrogin‐1 = muscle atrophy F‐box protein; MuRF1 = muscle ring‐finger protein‐1.
p < .05;
p < .001.
3.4. Differential mitochondrial gene expression, and effect of age on correlation with whole body protein kinetics
Expression of mitochondrial genes in older versus young muscle is shown in Figure 4. NRF1 was higher in the older adults (p < .01) compared with young adults. In the hierarchical analysis, we found that age has a significant moderating effect on the relationship between NRF1 gene expression and NB (ΔR 2 = 6.1%, p < .01; Table 4).
FIGURE 4.

Expression of mitochondrial biogenesis genes in skeletal muscle from young and old adults. PPARγ, peroxisome proliferator‐activated nuclear receptor‐gamma; PGC‐1α, peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha; Tfam, transcription factor A mitochondrial; UCP2, uncoupling protein 2; NRF1, nuclear respiratory factor 1. Values represent mean ± SD (young: n = 11, old: n = 19; *p < .05; Student t test with Holm–Sidak method)
TABLE 4.
Hierarchical regression analysis of correlation between mitochondrial biogenesis gene expression and whole‐body protein kinetics
| Mitochondrial biogenesis | PS | PB | NB | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | B | SE | β | ΔR2 | B | SE | β | ΔR2 | B | SE | β | ΔR2 |
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.293** | 0.133* | 0.345*** | |||||||||
| NRF1 | 0.352 | 0.098 | 0.543** | 0.195 | 0.092 | 0.366* | 0.156 | 0.040 | 0.589*** | |||
| Step3 | 0.203** | 0.046 | 0.444*** | |||||||||
| AGE | 0.172 | 0.048 | 0.609** | 0.068 | 0.053 | 0.291 | 0.104 | 0.012 | 0.900*** | |||
| Step4 | 0.027 | 0.006 | 0.061** | |||||||||
| NRF1 X AGE | −0.023 | 0.017 | −0.445 | −0.009 | 0.020 | −0.209 | −0.014 | 0.004 | −0.671** | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.011 | 0.042 | 0.026 | |||||||||
| PGC1α | 0.155 | 0.275 | 0.103 | 0.256 | 0.225 | 0.205 | −0.100 | 0.113 | −0.162 | |||
| Step3 | 0.485*** | 0.164* | 0.781*** | |||||||||
| AGE | 0.204 | 0.037 | 0.721*** | 0.098 | 0.040 | 0.419* | 0.106 | 0.009 | 0.915*** | |||
| Step4 | 0.006 | 0.007 | 0.000 | |||||||||
| PGC1α X AGE | −0.011 | 0.018 | −0.089 | −0.010 | 0.020 | −0.100 | −0.011 | 0.004 | −0.016 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.002 | 0.012 | 0.015 | |||||||||
| PPARγ | 0.026 | 0.118 | 0.041 | 0.058 | 0.098 | 0.113 | −0.032 | 0.049 | −0.126 | |||
| Step3 | 0.491*** | 0.170* | 0.775*** | |||||||||
| AGE | 0.206 | 0.037 | 0.729*** | 0.100 | 0.041 | 0.429* | 0.106 | 0.101 | 0.916*** | |||
| Step4 | 0.016 | 0.035 | 0.005 | |||||||||
| PPARγ X AGE | 0.005 | 0.005 | 0.127 | 0.006 | 0.005 | 0.190 | −0.001 | 0.001 | −0.072 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.092 | 0.109 | 0.006 | |||||||||
| Tfam | 0.465 | 0.2066 | 0.303 | 0.417 | 0.220 | 0.330 | .0.048 | 0.0116 | 0.076 | |||
| Step3 | 0.415*** | 0.114* | 0.795*** | |||||||||
| AGE | 0.193 | 0.038 | 0.682*** | 0.083 | 0.041 | 0.357* | 0.109 | 0.009 | 0.944*** | |||
| Step4 | 0.017 | 0.010 | 0.015 | |||||||||
| Tfam X AGE | −0.020 | 0.019 | −0.143 | −0.012 | 0.021 | −0.108 | −0.007 | 0.005 | −0.133 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.024 | 0.028 | 0.002 | |||||||||
| UCP2 | 0.114 | 0.132 | 0.160 | 0.101 | 0.110 | 0.172 | 0.013 | 0.055 | 0.043 | |||
| Step3 | 0.473*** | 0.154* | 0.786*** | |||||||||
| AGE | 0.201 | 0.037 | 0.712*** | 0.095 | 0.041 | 0.407* | 0.106 | 0.010 | 0.919*** | |||
| Step4 | 0.009 | 0.007 | 0.005 | |||||||||
| UCP2 X AGE | −0.006 | 0.008 | −0.133 | −0.004 | 0.009 | −0.114 | −0.002 | 0.002 | −0.095 | |||
Step 1 = control variable; Step 2 = independent variable; Step 3 = moderator variable; Step 4 = interaction terms; B = unstandardized regression coefficient; SE = standard errors for unstandardized regression coefficient; β = standardized regression coefficient; ΔR 2 = changes in R 2; PS = protein synthesis rate; PB = protein breakdown rate; NB = protein net balance; BMI = body mass index; NRF1 = nuclear respiratory factor 1; PGC1α = peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha; PPARγ = peroxisome proliferator‐activated receptor gamma. Tfam = mitochondrial transcription factor A; UCP2 = uncoupling protein 2.
p < .05;
p < .01;
p < .001.
3.5. Fatty acid metabolism gene expression in young and older adults, and effect of age on correlation with whole body protein kinetics
Expression of fatty acid metabolism genes in old versus young muscle is shown in Figure 5. FATP1, an insulin‐sensitive fatty acid transporter, was upregulated in the older adults compared with young adults (p < .001). The expression of the adipogenesis related gene, PPARα (p < .001), was significantly higher in the older adults compared with young adults. The fatty acid biogenesis‐related genes, SREBP1 (p < .01) and ACC (p < .01), were upregulated in the older adults. In the hierarchical analysis, we found that age has a significant moderating effect on the relationship between Cpt1 gene expression and PS (ΔR 2 = 6.3%, p < .05) or PB (ΔR 2 = 13.3%, p < .05; Table 5).
FIGURE 5.

Expression of fat metabolism genes in skeletal muscle from young and old adults. Cpt1b, carnitine palmitoyltransferase I; ACC, acetyl‐CoA carboxylase; FATP1, fatty acid transporter 1; FATP4, fatty acid transporter 4; PPARα, peroxisome proliferator‐activated nuclear receptor‐alpha; SREBP1, sterol regulatory element binding transcription factor 1. Values represent mean ± SD (young: n = 11, old: n = 19; *p < .05; Student t test with Holm–Sidak method)
TABLE 5.
Hierarchical regression analysis of correlation between fat metabolism gene expression and whole‐body protein kinetics
| Fat metabolism | PS | PB | NB | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | B | SE | β | ΔR 2 | B | SE | β | ΔR 2 | B | SE | β | ΔR 2 |
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.024 | 0.043 | 0.002 | |||||||||
| Cpt1 | ‐−0.072 | 0.084 | −0.159 | −0.080 | 0.070 | −0.215 | 0.008 | 0.036 | 0.045 | |||
| Step3 | 0.475*** | 0.155* | 0.790*** | |||||||||
| AGE | 0.202 | 0.037 | 0.714*** | 0.095 | 0.040 | 0.408* | 0.107 | 0.009 | 0.921*** | |||
| Step | 0.063* | 0.133* | 0.015 | |||||||||
| Cpt1 X AGE | −0.015 | 0.007 | −0.375* | −0.018 | 0.008 | −0.544* | 0.003 | 0.002 | 0.181 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.009 | 0.017 | 0.001 | |||||||||
| FATP1 | 0.061 | 0.120 | 0.097 | .0.071 | 0.100 | 0.136 | −0.010 | 0.050 | −0.037 | |||
| Step3 | 0.484*** | 0.162* | 0.787*** | |||||||||
| AGE | 0.203 | 0.037 | 0.720*** | 0.097 | 0.041 | 0.417* | 0.106 | 0.010 | 0.919*** | |||
| Step4 | 0.014 | 0.029 | 0.003 | |||||||||
| FATP1 X AGE | 0.005 | 0.005 | 0.119 | 0.006 | 0.006 | 0.172 | −0.001 | 0.001 | −0.056 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.012 | 0.024 | 0.002 | |||||||||
| FATP4 | 0.078 | 0.128 | 0.115 | .0.090 | 0.106 | 0.160 | −0.012 | 0.054 | −0.043 | |||
| Step3 | 0.482*** | 0.161* | 0.787*** | |||||||||
| AGE | 0.203 | 0.037 | 0.719*** | .0.097 | 0.041 | 0.415* | 0.106 | 0.010 | 0.919*** | |||
| Step | 0.016 | 0.032 | 0.003 | |||||||||
| FATP4 X AGE | 0.006 | 0.006 | 0.130 | 0.007 | 0.006 | 0.184 | −0.001 | 0.001 | −0.053 | |||
| Step1 | ||||||||||||
| BMI | 0.215 | 0.271 | 0.175 | 0.163 | 0.230 | 0.157 | 0.052 | 0.100 | 0.116 | |||
| Step2 | 0.056 | 0.005 | 0.239* | |||||||||
| PPARα | −0.232 | 0.214 | −0.257 | −0.057 | 0.186 | −0.075 | −0.174 | 0.071 | −0.528 | |||
| Step3 | 0.471*** | 0.227* | 0.603*** | |||||||||
| AGE | 0.223 | 0.051 | 0.776*** | 0.131 | 0.056 | 0.539* | 0.092 | 0.011 | 0.879*** | |||
| Step4 | 0.047 | 0.099 | 0.017 | |||||||||
| PPARα X AGE | −0.021 | 0.014 | −0.317 | −0.025 | 0.016 | −0.458 | 0.005 | 0.003 | 0.192 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.261 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.006 | 0.017 | 0.007 | |||||||||
| SREBP1 | 0.055 | 0.133 | 0.078 | .0.079 | 0.110 | 0.137 | −0.024 | 0.055 | −0.084 | |||
| Step3 | 0.488*** | 0.166* | 0.782*** | |||||||||
| AGE | 0.205 | 0.037 | 0.724*** | 0.098 | 0.041 | 0.422* | 0.106 | 0.010 | 0.917*** | |||
| Step4 | 0.018 | 0.041 | 0.006 | |||||||||
| SREBP1 X AGE | 0.006 | 0.006 | 0.138 | 0.007 | 0.006 | 0.206 | −0.001 | 0.001 | −0.078 | |||
| Step1 | ||||||||||||
| BMI | 0.302 | 0.207 | 0.207 | 0.208 | 0.173 | 0.217 | 0.094 | 0.086 | 0.199 | |||
| Step2 | 0.020 | 0.038 | 0.002 | |||||||||
| ACC | 0.086 | 0.110 | 0.301 | 0.097 | 0.091 | 0.202 | −0.012 | 0.046 | −0.049 | |||
| Step3 | 0.486*** | 0.163* | 0.786*** | |||||||||
| AGE | 0.204 | 0.037 | 0.722*** | 0.098 | 0.040 | 0.419* | 0.106 | 0.010 | 0.918*** | |||
| Step4 | 0.009 | 0.019 | 0.002 | |||||||||
| ACC X AGE | 0.004 | 0.005 | 0.098 | 0.004 | 0.005 | 0.140 | −0.001 | 0.001 | −0.044 | |||
Step 1 = control variable; Step 2 = independent variable; Step 3 = moderator variable; Step 4 = interaction terms; B = unstandardized regression coefficient; SE = standard errors for unstandardized regression coefficient; β = standardized regression coefficient; ΔR 2 = changes in R 2; PS = protein synthesis rate; PB = protein breakdown rate; NB = protein net balance; BMI = body mass index; Cpt1 = carnitine palmitoyltransferase 1; FATP1: fatty acid transport protein 1; FATP4 = fatty acid transport protein 4; PPARα = peroxisome proliferator‐activated receptor alpha; SREBP1 = sterol regulatory element‐binding transcription factor 1; ACC = acetyl‐CoA carboxylase.
p < .05;
p < .001.
4. DISCUSSION
To our knowledge, this is the first study to demonstrate that the expression of genes involved in the regulation of autophagy, UPS, mitochondrial biogenesis, and fat metabolism are differentially regulated in the skeletal muscle of young versus older adults. In addition, this is the first study, to our knowledge, to examine the correlation between age, WBPK, and expression of genes related to protein synthesis, protein breakdown, and energy metabolism (Figure 6).
FIGURE 6.

Schematic diagram showing dysregulated pathways in the skeletal muscle from older adults. Upregulated expression of p62, ATG7, Beclin1, and p53 may contribute to increased autophagy to further increase protein breakdown and mitophagy, which may be why a decrease in net protein balance was observed in the skeletal muscle of older adults. Decreased number of mitochondria may be caused by increased mitophagy in older adults
In the present study, markers of autophagy such as p62, ATG7, Beclin1, and p53, were upregulated in the skeletal muscle of older adults compared with young adults. This is supported by studies in skeletal muscle taken from older adults showing upregulated expression of p62 (Nogalska, Terracciano, D'Agostino, King Engel, & Askanas, 2009), and aging mice had higher cytosolic expression of p62 and Beclin1 (Sakuma et al., 2016). Consistent with the mice study (Sakuma et al., 2016), we found no differences in LC3B expression in older adults compared with young adults. One group of researchers showed that overexpression of GADD45A in the tibialis anterior muscle of healthy mice developed significant muscle atrophy (Bullard et al., 2016). However, we found no difference in expression of GADD45A and ATF4 between young and older adults. This discrepancy could be explained by the difference between artificial skeletal muscle atrophy in model animal and age‐related skeletal muscle dysfunction in humans. Interpreting our data in the context of the results reported by Sakuma et al (Sakuma et al., 2016), we suggest that autophagy could be dysregulated, especially upregulation of p62 and Beclin1. Over‐expression of these genes would facilitate the formation of autophagosome in the skeletal muscle in aged individuals, which could contribute to muscle loss. At the same time, the gene expression patterns of GADD45A and ATF4 under aging scenario need more investigation. Notably, a discrepancy exists between upregulated autophagy gene expression and decreased PB in older adults, compared with young adults. There are other multiple potential reasons for decreased PB in older adults: (a) physiologically, autophagy flux is affected by formation of autophagosome, fusion of autophagosome and lysosome, and the activity of lysosomal enzymes; (b) besides autophagy and UPS contribute to protein breakdown, calpain Ca2+‐dependent cysteine proteases also regulate protein breakdown; (c) the PB demonstrated here is a whole body protein breakdown rate, however, the pattern of muscle protein breakdown rate could be different with whole body protein breakdown rate.
E3 ubiquitin ligase is universally accepted as the central regulator of the UPS process (Ardley & Robinson, 2005). Overexpressed E3 ubiquitin ligase results in over‐activation of UPS and unnecessary protein degradation (Milan et al., 2015). Atrogin‐1 (Gomes, Lecker, Jagoe, Navon, & Goldberg, 2001) and MuRF1 (Bodine et al., 2001) are two well‐established skeletal muscle specific E3 ubiquitin ligases, which have been shown to be highly upregulated in mice with muscle atrophy (Tando et al., 2016). In addition, Atrogin‐1 and MuRF1 expression were upregulated in sedentary men who underwent 48 hr of unloading by unilateral lower limb suspension, a procedure to induce muscle disuse‐related atrophy (Reich, Chen, Thompson, Hoffman, & Clarkson, 2010). Another in vivo model of age‐related muscle loss showed downregulated expression of Atrogin‐1 and MuRF1 in the gastrocnemius muscle (Edstrom, Altun, Hagglund, & Ulfhake, 2006). In this study, we did not find differences in expressions of either Atrogin‐1 or MuRF1 between young and older adults. However, differences in inducing skeletal muscle loss in the animal models (such as dietary restriction‐induced atrophy vs. age‐related atrophy) could explain the contradictory results in the expression patterns of Atrogin‐1 and MuRF1.
Mitochondrial dysfunction has been widely reported in the skeletal muscle of older adults. Pre‐frail older adults have lower rates of ATP production, lower abundance of mitochondrial respiratory complex I, IV, and V and lower enzymatic activity of complex I, II, and IV compared to healthy active older adults (Andreux et al., 2018). Similarly, reduced cytochrome c oxidase (COX) activity and decreased expression of muscle specific PGC1α and COX I have been observed in low‐functioning older adults (Joseph et al., 2012). In the present study, we found that expression of PGC1α and PPARγ, two important transcription factors mediating mitochondrial biogenesis, did not differ between young and older adults. NRF1 expression was higher in skeletal muscle from older adults versus younger adults. These findings are supported by Lezza et al. (2001) who found an increase in NRF1 gene expression in skeletal muscle from older versus young adults. However, this same study also found an increase in Tfam gene expression with age (Lezza et al., 2001), where our results showed no difference in Tfam gene expression between older and young adults.
Increased fat deposition in aging skeletal muscle has been frequently reported (Tardif et al., 2014). It was previously shown that ACC, the rate‐limiting enzyme for fatty acid synthesis, was upregulated in the skeletal muscle of older adults, which is in line with our findings. In addition, PPARα is well known for mediating the activation of adipocyte differentiation during adipogenesis (Goto et al., 2011). Here, we also found upregulated levels of PPARα gene expression in skeletal muscle from older adults. Therefore, we suggest that elevated fat deposition could be the results of enhanced fatty acid synthesis and adipogenesis activation caused by ACC and PPARα upregulation. FATP1 and FATP4, two skeletal muscle abundant fatty acid transport proteins, were reported to be differentially expressed in the muscle of exercised healthy young adults (Jeppesen et al., 2012). In another in vivo model of muscle hypertrophy using myostatin knockout mice, density of muscle FATP1 and FATP4 proteins were lower than wild‐type (Baati et al., 2017). These studies suggest FATP1 and FATP4 are upregulated with muscle growth. However, we found that FATP1 and FATP4 are upregulated in the skeletal muscle of older adults. But notably, despite the fact that upregulated FATP1 and FATP4 levels would suggest higher fatty acid transport capacity for oxidation, unchanged gene expression of Cpt1b, the rate‐limiting enzyme for fatty acid oxidation, between young and old adults in our study would explain the deficiency in fatty acid catabolism reported elsewhere. As a transcription factor that regulates fatty acid synthesis in lipogenic tissues, overexpression of SREBP1 was also shown to induce muscle atrophy and decreases protein synthesis rate in an in vitro model of human skeletal muscle (Dessalle et al., 2012). Consistent with this, we found upregulated SREBP1 levels in the skeletal muscle of older adults.
It was present that obese adults had significantly lower whole body and muscle protein synthesis rate versus lean counterparts (Guillet et al., 2009). However, this study did not measure whole body and muscle protein breakdown rate, in which net balance between protein synthesis and breakdown was unknown. Another study measured WBPK showed no difference in net balance between lean and obese adults (Gougeon et al., 2008). In present study, we also did not observe any difference in net balance between normal weight and overweight and obese adults. Hierarchical regression analysis revealed that autophagy, UPS, mitochondrial biogenesis, and fat metabolism‐related genes were not correlated with WBPK (PS, PB, and NB) after introducing BMI as moderator. Therefore, we concluded that these gene expressions could not be used as predictor for WBPK.
There are several limitations to this study. First, we only measured the gene expression of selected genes between two age groups, and further validation of gene expression via immunoblotting was not conducted. Any difference found on the transcription level might not be reflective of the protein level or enzymatic activity. Second, we only determined the correlations between WBPK and expression of genes related to selected pathways, and the correlations do not completely reflect the causality. In addition, we only compared the differences in WBPK between young and older adults. Previously, Volpi et al. (Volpi et al., 2001) reported that muscle protein fractional synthesis rate was not different between young and old adults. However, muscle protein breakdown rate was not measured in this study. Finally, there are additional genes which could have been measured in this study related to the proteasome pathway, such a NEDD4, TRIM32, and Fbxo30, but were not measured due to limited sample availability.
Taken together, this is the first study to examine the correlation between skeletal muscle gene expression related to protein breakdown, mitochondrial biogenesis, fat metabolism, and whole‐body protein kinetics in young versus older adults. However, further research is needed to define the mechanisms that link WBPK to skeletal muscle function in aging adults.
CONFLICT OF INTEREST
The authors have no conflicts of interest to disclose.
AUTHOR CONTRIBUTIONS
JIB and RRW conceptualized the idea for the project. HW and SD conducted the gene analysis. RRW, I‐YK, and AAF designed, implemented, analyzed, and reported the initial data from the human muscle biopsy studies. HW had primary responsibility for writing the first draft of the manuscript and making the figures. JJ and I‐YK conducted the correlation analysis and had primary responsibility for making the tables. All authors had input in the study interpretation and conclusions. All authors reviewed and approved the manuscript before submission.
Supporting information
Table S1
ACKNOWLEDGMENTS
The authors would like to acknowledge Cosby J. Lasley for coordinating subjects for the two studies used for analysis in the manuscript. Scott Schutzler for his conducting stable isotope tracer infusion studies. Rick Williams for his liquid and gas‐chromatography mass‐spectrometry analysis. Deb Viane for her administrative assistance.
Wu H, Jang J, Dridi S, et al. Net protein balance correlates with expression of autophagy, mitochondrial biogenesis, and fat metabolism‐related genes in skeletal muscle from older adults. Physiol Rep. 2020;8:e14575 10.14814/phy2.14575
Contributor Information
Il‐Young Kim, Email: iykim@gachon.ac.kr.
Jamie I. Baum, Email: baum@uark.edu.
DATA AVAILABILITY STATEMENT
All raw data may be requested from the corresponding authors via email. Contact J.I.B. for gene analysis data and I‐Y.K. for correlation analysis data.
REFERENCES
- Aickin, M. , & Gensler, H. (1996). Adjusting for multiple testing when reporting research results: The Bonferroni vs Holm methods. American Journal of Public Health, 86, 726–728. 10.2105/AJPH.86.5.726 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Altun, M. , Besche, H. C. , Overkleeft, H. S. , Piccirillo, R. , Edelmann, M. J. , Kessler, B. M. , … Ulfhake, B. (2010). Muscle wasting in aged, sarcopenic rats is associated with enhanced activity of the ubiquitin proteasome pathway. The Journal of Biological Chemistry, 285, 39597–39608. 10.1074/jbc.M110.129718 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Andreux, P. A. , van Diemen, M. P. J. , Heezen, M. R. , Auwerx, J. , Rinsch, C. , Groeneveld, G. J. , & Singh, A. (2018). Mitochondrial function is impaired in the skeletal muscle of pre‐frail elderly. Scientific Reports, 8, 8548 10.1038/s41598-018-26944-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ardley, H. C. , & Robinson, P. A. (2005). E3 ubiquitin ligases. Essays in Biochemistry, 41, 15–30. 10.1042/EB0410015 [DOI] [PubMed] [Google Scholar]
- Baati, N. , Feillet‐Coudray, C. , Fouret, G. , Vernus, B. , Goustard, B. , Coudray, C. , … Koechlin‐Ramonatxo, C. (2017). Myostatin deficiency is associated with lipidomic abnormalities in skeletal muscles. Biochimica et Biophysica Acta Molecular and Cell Biology of Lipids, 1862, 1044–1055. 10.1016/j.bbalip.2017.06.017 [DOI] [PubMed] [Google Scholar]
- Baehr, L. M. , West, D. W. , Marcotte, G. , Marshall, A. G. , De Sousa, L. G. , Baar, K. , & Bodine, S. C. (2016). Age‐related deficits in skeletal muscle recovery following disuse are associated with neuromuscular junction instability and ER stress, not impaired protein synthesis. Aging, 8, 127–146. 10.18632/aging.100879 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baum, J. I. , Kim, I. Y. , & Wolfe, R. R. (2016). Protein consumption and the elderly: What is the optimal level of intake? Nutrients, 8, 359 10.3390/nu8060359 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blaak, E. E. , van Baak, M. A. , & Saris, W. H. (1999). Beta‐adrenergically stimulated fat oxidation is diminished in middle‐aged compared to young subjects. The Journal of Clinical Endocrinology and Metabolism, 84, 3764–3769. [DOI] [PubMed] [Google Scholar]
- Bodine, S. C. , Latres, E. , Baumhueter, S. , Lai, V. K. , Nunez, L. , Clarke, B. A. , … Glass, D. J. (2001). Identification of ubiquitin ligases required for skeletal muscle atrophy. Science, 294, 1704–1708. 10.1126/science.1065874 [DOI] [PubMed] [Google Scholar]
- Buch, A. , Carmeli, E. , Boker, L. K. , Marcus, Y. , Shefer, G. , Kis, O. , … Stern, N. (2016). Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age–An overview. Experimental Gerontology, 76, 25–32. 10.1016/j.exger.2016.01.008 [DOI] [PubMed] [Google Scholar]
- Bullard, S. A. , Seo, S. , Schilling, B. , Dyle, M. C. , Dierdorff, J. M. , Ebert, S. M. , … Adams, C. M. (2016). Gadd45a protein promotes skeletal muscle atrophy by forming a complex with the protein kinase MEKK4. The Journal of Biological Chemistry, 291, 17496–17509. 10.1074/jbc.M116.740308 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carter, H. N. , Kim, Y. , Erlich, A. T. , Zarrin‐Khat, D. , & Hood, D. A. (2018). Autophagy and mitophagy flux in young and aged skeletal muscle following chronic contractile activity. The Journal of Physiology, 596, 3567–3584. 10.1113/JP275998 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clavel, S. , Coldefy, A. S. , Kurkdjian, E. , Salles, J. , Margaritis, I. , & Derijard, B. (2006). Atrophy‐related ubiquitin ligases, atrogin‐1 and MuRF1 are up‐regulated in aged rat Tibialis Anterior muscle. Mechanisms of Ageing and Development, 127, 794–801. 10.1016/j.mad.2006.07.005 [DOI] [PubMed] [Google Scholar]
- Cuthbertson, D. , Smith, K. , Babraj, J. , Leese, G. , Waddell, T. , Atherton, P. , … Rennie, M. J. (2005). Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 19, 422–424. 10.1096/fj.04-2640fje [DOI] [PubMed] [Google Scholar]
- Dessalle, K. , Euthine, V. , Chanon, S. , Delarichaudy, J. , Fujii, I. , Rome, S. , … Lefai, E. (2012). SREBP‐1 transcription factors regulate skeletal muscle cell size by controlling protein synthesis through myogenic regulatory factors. PLoS One, 7, e50878 10.1371/journal.pone.0050878 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Drummond, M. J. , Addison, O. , Brunker, L. , Hopkins, P. N. , McClain, D. A. , LaStayo, P. C. , & Marcus, R. L. (2014). Downregulation of E3 ubiquitin ligases and mitophagy‐related genes in skeletal muscle of physically inactive, frail older women: A cross‐sectional comparison. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences, 69, 1040–1048. 10.1093/gerona/glu004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ebert, S. M. , Bullard, S. A. , Basisty, N. , Marcotte, G. R. , Skopec, Z. P. , Dierdorff, J. M. , … Adams, C. M. (2020). Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBPbeta. The Journal of Biological Chemistry. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edstrom, E. , Altun, M. , Hagglund, M. , & Ulfhake, B. (2006). Atrogin‐1/MAFbx and MuRF1 are downregulated in aging‐related loss of skeletal muscle. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences, 61, 663–674. 10.1093/gerona/61.7.663 [DOI] [PubMed] [Google Scholar]
- Fox, D. K. , Ebert, S. M. , Bongers, K. S. , Dyle, M. C. , Bullard, S. A. , Dierdorff, J. M. , … Adams, C. M. (2014). p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization. American Journal of Physiology Endocrinology and Metabolism, 307, E245–261. 10.1152/ajpendo.00010.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fry, C. S. , Drummond, M. J. , Glynn, E. L. , Dickinson, J. M. , Gundermann, D. M. , Timmerman, K. L. , … Rasmussen, B. B. (2013). Skeletal muscle autophagy and protein breakdown following resistance exercise are similar in younger and older adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 68, 599–607. 10.1093/gerona/gls209 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gillespie, L. D. , Robertson, M. C. , Gillespie, W. J. , Sherrington, C. , Gates, S. , Clemson, L. M. , & Lamb, S. E. (2012). Interventions for preventing falls in older people living in the community. The Cochrane Database of Systematic Reviews. CD007146 10.1002/14651858.CD007146.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gomes, M. D. , Lecker, S. H. , Jagoe, R. T. , Navon, A. , & Goldberg, A. L. (2001). Atrogin‐1, a muscle‐specific F‐box protein highly expressed during muscle atrophy. Proceedings of the National Academy of Sciences of the United States of America, 98, 14440–14445. 10.1073/pnas.251541198 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goto, T. , Lee, J. Y. , Teraminami, A. , Kim, Y. I. , Hirai, S. , Uemura, T. , … Kawada, T. (2011). Activation of peroxisome proliferator‐activated receptor‐alpha stimulates both differentiation and fatty acid oxidation in adipocytes. Journal of Lipid Research, 52, 873–884. 10.1194/jlr.M011320 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gougeon, R. , Morais, J. A. , Chevalier, S. , Pereira, S. , Lamarche, M. , & Marliss, E. B. (2008). Determinants of whole‐body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care, 31, 128–133. 10.2337/dc07-1268 [DOI] [PubMed] [Google Scholar]
- Guillet, C. , Delcourt, I. , Rance, M. , Giraudet, C. , Walrand, S. , Bedu, M. , … Boirie, Y. (2009). Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. The Journal of Clinical Endocrinology and Metabolism, 94, 3044–3050. 10.1210/jc.2008-2216 [DOI] [PubMed] [Google Scholar]
- Guillet, C. , Prod'homme, M. , Balage, M. , Gachon, P. , Giraudet, C. , Morin, L. , … Boirie, Y. (2004). Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 18, 1586–1587. 10.1096/fj.03-1341fje [DOI] [PubMed] [Google Scholar]
- Guo, Z. , & Jensen, M. D. (2013). Arterio‐venous balance studies of skeletal muscle fatty acid metabolism: What can we believe? American Journal of Physiology Endocrinology and Metabolism, 305, E925–930. 10.1152/ajpendo.00346.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hamrick, M. W. , McGee‐Lawrence, M. E. , & Frechette, D. M. (2016). Fatty infiltration of skeletal muscle: Mechanisms and comparisons with bone marrow adiposity. Frontiers in Endocrinology, 7, 69 10.3389/fendo.2016.00069 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Janssen, I. , Heymsfield, S. B. , & Ross, R. (2002). Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. Journal of the American Geriatrics Society, 50, 889–896. 10.1046/j.1532-5415.2002.50216.x [DOI] [PubMed] [Google Scholar]
- Jeppesen, J. , Jordy, A. B. , Sjoberg, K. A. , Fullekrug, J. , Stahl, A. , Nybo, L. , & Kiens, B. (2012). Enhanced fatty acid oxidation and FATP4 protein expression after endurance exercise training in human skeletal muscle. PLoS One, 7, e29391 10.1371/journal.pone.0029391 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Joseph, A. M. , Adhihetty, P. J. , Buford, T. W. , Wohlgemuth, S. E. , Lees, H. A. , Nguyen, L. M. , … Leeuwenburgh, C. (2012). The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high‐ and low‐functioning elderly individuals. Aging Cell, 11, 801–809. 10.1111/j.1474-9726.2012.00844.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Katsanos, C. S. , Kobayashi, H. , Sheffield‐Moore, M. , Aarsland, A. , & Wolfe, R. R. (2005). Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. The American Journal of Clinical Nutrition, 82, 1065–1073. 10.1093/ajcn/82.5.1065 [DOI] [PubMed] [Google Scholar]
- Kim, I. , Rodriguez‐Enriquez, S. , & Lemasters, J. J. (2007). Selective degradation of mitochondria by mitophagy. Archives of Biochemistry and Biophysics, 462, 245–253. 10.1016/j.abb.2007.03.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim, I. Y. , Schutzler, S. , Schrader, A. , Spencer, H. J. , Azhar, G. , Ferrando, A. A. , & Wolfe, R. R. (2016). The anabolic response to a meal containing different amounts of protein is not limited by the maximal stimulation of protein synthesis in healthy young adults. American Journal of Physiology Endocrinology and Metabolism, 310, E73–E80. 10.1152/ajpendo.00365.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim, I. Y. , Schutzler, S. , Schrader, A. , Spencer, H. , Kortebein, P. , Deutz, N. E. , … Ferrando, A. A. (2015). Quantity of dietary protein intake, but not pattern of intake, affects net protein balance primarily through differences in protein synthesis in older adults. American Journal of Physiology. Endocrinology and Metabolism, 308, E21–E28. 10.1152/ajpendo.00382.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim, I. Y. , Suh, S. H. , Lee, I. K. , & Wolfe, R. R. (2016). Applications of stable, nonradioactive isotope tracers in in vivo human metabolic research. Experimental & Molecular Medicine, 48, e203 10.1038/emm.2015.97 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Levine, B. , & Klionsky, D. J. (2004). Development by self‐digestion: Molecular mechanisms and biological functions of autophagy. Developmental Cell, 6, 463–477. 10.1016/S1534-5807(04)00099-1 [DOI] [PubMed] [Google Scholar]
- Lezza, A. M. , Pesce, V. , Cormio, A. , Fracasso, F. , Vecchiet, J. , Felzani, G. , … Gadaleta, M. N. (2001). Increased expression of mitochondrial transcription factor A and nuclear respiratory factor‐1 in skeletal muscle from aged human subjects. FEBS Letters, 501, 74–78. 10.1016/S0014-5793(01)02628-X [DOI] [PubMed] [Google Scholar]
- Livak, K. J. , & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real‐time quantitative PCR and the 2(‐Delta Delta C(T)) Method. Methods, 25, 402–408. [DOI] [PubMed] [Google Scholar]
- Living AfC . (2018). 2018 profile of older Americans.
- Milan, G. , Romanello, V. , Pescatore, F. , Armani, A. , Paik, J. H. , Frasson, L. , … Sandri, M. (2015). Regulation of autophagy and the ubiquitin‐proteasome system by the FoxO transcriptional network during muscle atrophy. Nature Communications, 6, 6670 10.1038/ncomms7670 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neel, B. A. , Lin, Y. , & Pessin, J. E. (2013). Skeletal muscle autophagy: A new metabolic regulator. Trends in Endocrinology and Metabolism: TEM, 24, 635–643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nogalska, A. , Terracciano, C. , D'Agostino, C. , King Engel, W. , & Askanas, V. (2009). p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion‐body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathologica, 118, 407–413. 10.1007/s00401-009-0564-6 [DOI] [PubMed] [Google Scholar]
- Reich, K. A. , Chen, Y. W. , Thompson, P. D. , Hoffman, E. P. , & Clarkson, P. M. (2010). Forty‐eight hours of unloading and 24 h of reloading lead to changes in global gene expression patterns related to ubiquitination and oxidative stress in humans. Journal of Applied Physiology, 109, 1404–1415. 10.1152/japplphysiol.00444.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sakuma, K. , Kinoshita, M. , Ito, Y. , Aizawa, M. , Aoi, W. , & Yamaguchi, A. (2016). p62/SQSTM1 but not LC3 is accumulated in sarcopenic muscle of mice. Journal of Cachexia, Sarcopenia and Muscle, 7, 204–212. 10.1002/jcsm.12045 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandri, M. (2010). Autophagy in skeletal muscle. FEBS Letters, 584, 1411–1416. 10.1016/j.febslet.2010.01.056 [DOI] [PubMed] [Google Scholar]
- Short, K. R. , Vittone, J. L. , Bigelow, M. L. , Proctor, D. N. , & Nair, K. S. (2004). Age and aerobic exercise training effects on whole body and muscle protein metabolism. American Journal of Physiology Endocrinology and Metabolism, 286, E92–E101. 10.1152/ajpendo.00366.2003 [DOI] [PubMed] [Google Scholar]
- Tando, T. , Hirayama, A. , Furukawa, M. , Sato, Y. , Kobayashi, T. , Funayama, A. , … Miyamoto, T. (2016). Smad2/3 Proteins Are Required for Immobilization‐induced Skeletal Muscle Atrophy. The Journal of Biological Chemistry, 291, 12184–12194. 10.1074/jbc.M115.680579 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tardif, N. , Salles, J. , Guillet, C. , Tordjman, J. , Reggio, S. , Landrier, J. F. , … Walrand, S. (2014). Muscle ectopic fat deposition contributes to anabolic resistance in obese sarcopenic old rats through eIF2alpha activation. Aging Cell, 13, 1001–1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vellas, B. J. , Wayne, S. J. , Romero, L. J. , Baumgartner, R. N. , & Garry, P. J. (1997). Fear of falling and restriction of mobility in elderly fallers. Age and Ageing, 26, 189–193. 10.1093/ageing/26.3.189 [DOI] [PubMed] [Google Scholar]
- Volpi, E. , Sheffield‐Moore, M. , Rasmussen, B. B. , & Wolfe, R. R. (2001). Basal muscle amino acid kinetics and protein synthesis in healthy young and older men. JAMA, 286, 1206–1212. 10.1001/jama.286.10.1206 [DOI] [PMC free article] [PubMed] [Google Scholar]
- White, Z. , Terrill, J. , White, R. B. , McMahon, C. , Sheard, P. , Grounds, M. D. , & Shavlakadze, T. (2016). Voluntary resistance wheel exercise from mid‐life prevents sarcopenia and increases markers of mitochondrial function and autophagy in muscles of old male and female C57BL/6J mice. Skeletal Muscle, 6, 45 10.1186/s13395-016-0117-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolfe, R. R. C. D. (2005). Isotope tracers in metabolic reserach (2nd ed.). Hoboken, NJ: Wiley. [Google Scholar]
- Zhang, J. (2013). Autophagy and mitophagy in cellular damage control. Redox Biology, 1, 19–23. 10.1016/j.redox.2012.11.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhou, J. , Chong, S. Y. , Lim, A. , Singh, B. K. , Sinha, R. A. , Salmon, A. B. , & Yen, P. M. (2017). Changes in macroautophagy, chaperone‐mediated autophagy, and mitochondrial metabolism in murine skeletal and cardiac muscle during aging. Aging, 9, 583–599. 10.18632/aging.101181 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Table S1
Data Availability Statement
All raw data may be requested from the corresponding authors via email. Contact J.I.B. for gene analysis data and I‐Y.K. for correlation analysis data.
